| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2495743C Fusion proteins and methods of producing same |
| 01/25/2011 | CA2430182C Prokaryotically produced antibodies and uses thereof |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2321089C Human homolog of the drosophila protein "fused" |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110015376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production |
| 01/20/2011 | US20110014675 Poly zinc finger proteins with improved linkers |
| 01/20/2011 | US20110014216 Drug Transfer Based on Coenzyme A and Acyl Carrier Protein |
| 01/20/2011 | CA2768299A1 Bifunctional stapled polypeptides and uses thereof |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2274336A2 Mutants of streptokinase and their covalently modified forms |
| 01/19/2011 | EP1423419B1 Hybrid and tandem expression of neisserial proteins |
| 01/19/2011 | EP1224299B1 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 01/19/2011 | CN101952321A Recombinant RSV antigens |
| 01/19/2011 | CN101952320A Material with immunogenicity |
| 01/19/2011 | CN101952314A Biokinetics of fast-clearing polypeptides |
| 01/19/2011 | CN101948853A Thermophilic fat bacillus DNA polymerase |
| 01/19/2011 | CN101948837A Method for producing human insulin growth factor-1 in recombinant Escherichia coli |
| 01/19/2011 | CN101948546A Fusion protein SAmB as well as coding gene and applications thereof |
| 01/19/2011 | CN101948545A IgG antibody affinity peptide-alkaline phosphatase fusion protein |
| 01/19/2011 | CN101948544A FAT10 gene siRNA recombination analogue virus as well as preparation method and application thereof |
| 01/19/2011 | CN101948543A Fusion protein and coding gene and application thereof |
| 01/19/2011 | CN101289514B Process for cultivating stress-tolerant plants and special DNA fragments thereof |
| 01/18/2011 | US7872107 Interleukin-12p40 variants with improved stability |
| 01/18/2011 | CA2637795C Antagonists of interleukin-15 |
| 01/18/2011 | CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence |
| 01/13/2011 | WO2011005523A2 Galectin-immunoglobulin chimeric molecules |
| 01/13/2011 | WO2010102277A3 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion |
| 01/13/2011 | WO2010091441A3 Stable, functional chimeric cellobiohydrolases |
| 01/13/2011 | US20110010804 Genes that increase plant oil and method for using the same |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008249 Proteins with high immunoreactivity and method for their production |
| 01/13/2011 | CA2766166A1 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering |
| 01/12/2011 | EP2272864A2 Binding agents which inhibit myostatin |
| 01/12/2011 | EP2272861A1 Polyepitope carrier protein |
| 01/12/2011 | EP2272859A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 01/12/2011 | EP2272533A1 Soluble FcyR fusion proteins and methods of use thereof |
| 01/12/2011 | EP1991586B1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 01/12/2011 | EP1704167B1 A method to make a peptide-carrier conjugate with a high immunogenicity |
| 01/12/2011 | EP1548107B1 Chromoprotein and fluoroproteins |
| 01/12/2011 | EP1105479B1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 01/12/2011 | CN1816566B VEGF traps and therapeutic uses thereof |
| 01/12/2011 | CN1688605B Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes |
| 01/12/2011 | CN101942026A Long-acting interferon fusion protein and application thereof |
| 01/12/2011 | CN101942025A Heparanase III fusion protein and coding gene and expression method thereof |
| 01/12/2011 | CN101942024A Heparanase II fusion protein and coding gene and expression method thereof |
| 01/12/2011 | CN101942023A Human epidermic growth factor ferritin heavy chain subunit fusion protein, constructing method and use thereof |
| 01/12/2011 | CN101942022A Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof |
| 01/12/2011 | CN101942021A Hepatitis C virus specific antigen and application thereof in serotype |
| 01/12/2011 | CN101942020A Streptavidin/interleukin-7 fusion protein |
| 01/12/2011 | CN101157729B Tumour putrescence gene related apoptosis ligand variant and uses thereof |
| 01/11/2011 | US7868150 Nucleic acids encoding T2R taste receptors |
| 01/11/2011 | US7867502 Genetic engineered polypeptides; useful candidates in a vaccine against tuberculosis (TB) or diagnostic preparation for TB; vaccine; inhibit mycobacterial virulence |
| 01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
| 01/11/2011 | US7867481 Method of treating anemia by administering IL-1ra |
| 01/06/2011 | WO2011002977A2 Genetically encoded photomanipulation of protein and peptide activity |
| 01/06/2011 | WO2010095881A3 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof |
| 01/06/2011 | WO2009122442A3 Mutants of streptokinase and their covalently modified forms |
| 01/06/2011 | US20110003340 Synthetic genes for plant gums and other hydroxyproline-rich proteins |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/06/2011 | US20110002955 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | CA2767063A1 Novel therapeutic and diagnostic means |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270055A2 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270031A2 Heterologous expression of neisserial proteins |
| 01/05/2011 | EP2270030A2 Heterologous expression of Neisserial proteins |
| 01/05/2011 | EP2270027A1 Polypeptides having brain-localizing activity and uses thereof |
| 01/05/2011 | EP2269634A2 Antigenic polypeptides |
| 01/05/2011 | EP2268673A2 Polypeptide-polymer conjugates and methods of use thereof |
| 01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
| 01/05/2011 | CN101935354A Human cardiac troponin T/ human cardiac troponin I fusion protein |
| 01/05/2011 | CN101935353A Strepavidin/sCD40L fusion protein |
| 01/05/2011 | CN101935352A Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 01/05/2011 | CN101935351A Human vascuoar endothelial cell growth factor analogue |
| 01/05/2011 | CN101934076A Bivalent marking live attenuated vaccine of non-propagation genetic engineering for resisting classical swine fever and Japanese encephalitis and application |
| 01/05/2011 | CN101003812B Method for preparing recombined EGF-IL18 fusion protein of human |
| 01/04/2011 | US7863017 TAT-utrophin as a protein therapy for dystrophinopathies |
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | CA2459013C Proteins having effects of controlling cell migration and cell death |
| 01/04/2011 | CA2389206C Activation of hcv-specific t cells |
| 01/04/2011 | CA2301920C Vaccine |
| 12/30/2010 | US20100331251 Polypeptides homologous to vegf and bmp1 |
| 12/30/2010 | US20100331246 Ester-based insulin prodrugs |
| 12/30/2010 | US20100330667 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/30/2010 | US20100330590 Assays using chimeric t1r3 taste receptor polypeptides |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |